Managers | François RIVOLIER |
Location | Paris (75) |
Creation | 2018 |
Equity investment | 2020 |
Read more | |
Mission | An evergreen investment company backed by a unique community of entrepreneurs, GENEO supports SMEs and mid-cap companies, giving them the means to achieve their ambitions.
GÉNÉO CAPITAL and GÉNÉO MEZZANINE are funds dedicated to the mid-cap market, created in 2017 and 2022. These funds are unique in that they target companies that have never been involved in a financial transaction and whose capital is still mainly held by family shareholders. Their added value is based on operational support from the investment team and their network of experts and entrepreneurs, and on a "patient capital" approach that is free from the time constraints of traditional funds.
GÉNÉO CAPITAL and GÉNÉO MEZZANINE invest between €1 million and €15 million in minority transactions. |